Bourne Lent Asset Management Inc Abbott Laboratories Transaction History
Bourne Lent Asset Management Inc
- $263 Million
- Q3 2024
A detailed history of Bourne Lent Asset Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Bourne Lent Asset Management Inc holds 2,498 shares of ABT stock, worth $291,766. This represents 0.11% of its overall portfolio holdings.
Number of Shares
2,498
Previous 2,568
2.73%
Holding current value
$291,766
Previous $266,000
6.77%
% of portfolio
0.11%
Previous 0.1%
Shares
4 transactions
Others Institutions Holding ABT
# of Institutions
3,177Shares Held
1.33BCall Options Held
8.62MPut Options Held
7.18M-
Vanguard Group Inc Valley Forge, PA166MShares$19.4 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$15.3 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.69 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.39 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.69 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $205B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...